Evaxion Biotech A/S. (7/1/17). "Press Release: Lars Wegner Joins Evaxion Biotech".

	Organisation	Evaxion Biotech A/S (Nasdaq: EVAX)
	Organisation 2	Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY)
	Group	Bavarian Nordic (Group)
	Product	AI-immunology™ platform
	Product 2	vaccine
	Person	Wegner, Lars Staal (Evaxion Biotech 201707– CEO before 10y at Bavarian Nordic before Pfizer)
	Person 2	Møller, Niels Eversen (Evaxion Biotech 202102 CBO before CEO + Co-founder before Medical Prognosis + AstraZeneca)

Lars Wegner, M.D., has been appointed as Evaxion’s new Chief Executive Officer in addition to his current role as Board Member. Niels Møller, outgoing Chief Executive Officer, will continue in the combined role of Chief Operational Officer and Chief Medical Officer.

Lars brings extensive experience from the vaccine industry, first at Pfizer and then 10 years as part of the Senior Management in Bavarian Nordic, a listed immuno-oncology and vaccine company. Lars has previous been involved in multiple start-ups and early ventures and is also a Founding Investor of Evaxion. Lars will oversee the continued growth of the company and the Evaxion team is excited to get Lars on-board full time and leverage his experience to ensure that Evaxion reaches its aspiration.

Record changed: 2021-03-22

Picture BIO Deutschland German Corona Special 2021 Digital 650x80px

More documents for Evaxion Biotech A/S (Nasdaq: EVAX)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]